APA (7th ed.) Citation

RMA, A., AM, E., MA, S., M, E., MG, K., E, A., . . . MA, T. (2023). Formulation, optimization, in-vivo biodistribution studies and histopathological safety assessment of duloxetine HCl-loaded ultra-elastic nanovesicles for antidepressant effect after intranasal and transdermal delivery. International journal of pharmaceutics: X, 6, 100194. https://doi.org/10.1016/j.ijpx.2023.100194

Chicago Style (17th ed.) Citation

RMA, Abd-Elal, Essawy AM, Salem MA, Elsayed M, Khalil MG, Abdelhakeem E, Ali NA, and Tawfik MA. "Formulation, Optimization, In-vivo Biodistribution Studies and Histopathological Safety Assessment of Duloxetine HCl-loaded Ultra-elastic Nanovesicles for Antidepressant Effect After Intranasal and Transdermal Delivery." International Journal of Pharmaceutics: X 6 (2023): 100194. https://doi.org/10.1016/j.ijpx.2023.100194.

MLA (9th ed.) Citation

RMA, Abd-Elal, et al. "Formulation, Optimization, In-vivo Biodistribution Studies and Histopathological Safety Assessment of Duloxetine HCl-loaded Ultra-elastic Nanovesicles for Antidepressant Effect After Intranasal and Transdermal Delivery." International Journal of Pharmaceutics: X, vol. 6, 2023, p. 100194, https://doi.org/10.1016/j.ijpx.2023.100194.